Real-time Anatomy Recognition Tool Accuracy Research for Ultrasound-guided PENG and Suprainguinal Fascia Iliaca Blocks
Launched by KONYA CITY HOSPITAL · Feb 22, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new tool that uses artificial intelligence to help doctors improve the accuracy of ultrasound images during certain pain relief procedures, specifically nerve blocks. The goal is to make it safer for patients by reducing the chances of unintentional injuries to nerves or nearby tissues. By using this AI tool, doctors can better identify important anatomical structures, which can lead to fewer complications during the procedure.
To participate in this trial, individuals must be healthy adults between the ages of 18 and 65 who are willing to have ultrasound images taken. Those with existing health conditions, pregnant individuals, or those under 18 years old are not eligible. Participants can expect to undergo ultrasound imaging with this new AI tool, which aims to enhance the safety and effectiveness of nerve block procedures. Overall, this trial is an exciting step towards improving patient care and minimizing risks associated with pain management techniques.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Agreeing to take ultrasound images
- • Healthy - No comorbidities
- • Adult individuals between the ages of 18-65
- Exclusion Criteria:
- • Those who do not accept ultrasound images
- • Individuals under 18 years of age
- • with comorbidities
- • Pregnancy
About Konya City Hospital
Konya City Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a focus on collaborative research, the hospital integrates state-of-the-art facilities and a multidisciplinary team of experienced professionals. By participating in clinical trials, Konya City Hospital aims to contribute to the development of new therapies and enhance the understanding of various medical conditions, ultimately benefiting both the local community and the broader medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, Meram, Turkey
Patients applied
Trial Officials
Yasin Tire
Principal Investigator
Konya City Hospital
Betül Afşar
Study Director
Konya City Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported